- Home
- ECOR vs SER Comparison
ECOR vs SER Comparison
Compare ECOR & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- SER
- Stock Information
- Founded
- ECOR 2005
- SER 2017
- Country
- ECOR United States
- SER United States
- Employees
- ECOR N/A
- SER N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- ECOR Health Care
- SER Health Care
- Exchange
- ECOR Nasdaq
- SER Nasdaq
- Market Cap
- ECOR 57.5M
- SER 47.5M
- IPO Year
- ECOR 2018
- SER 2018
- Fundamental
- Price
- ECOR $6.69
- SER $5.82
- Analyst Decision
- ECOR Strong Buy
- SER Strong Buy
- Analyst Count
- ECOR 2
- SER 1
- Target Price
- ECOR $25.50
- SER $11.00
- AVG Volume (30 Days)
- ECOR 216.5K
- SER 9.7K
- Earning Date
- ECOR 03-12-2025
- SER 03-24-2025
- Dividend Yield
- ECOR N/A
- SER N/A
- EPS Growth
- ECOR N/A
- SER N/A
- EPS
- ECOR N/A
- SER N/A
- Revenue
- ECOR $25,182,000.00
- SER $56,000.00
- Revenue This Year
- ECOR $40.88
- SER N/A
- Revenue Next Year
- ECOR $48.01
- SER N/A
- P/E Ratio
- ECOR N/A
- SER N/A
- Revenue Growth
- ECOR 57.09
- SER N/A
- 52 Week Low
- ECOR $5.32
- SER $3.81
- 52 Week High
- ECOR $19.49
- SER $14.57
- Technical
- Relative Strength Index (RSI)
- ECOR 19.00
- SER 71.28
- Support Level
- ECOR $6.57
- SER $4.60
- Resistance Level
- ECOR $8.25
- SER $4.85
- Average True Range (ATR)
- ECOR 0.92
- SER 0.39
- MACD
- ECOR -0.15
- SER 0.13
- Stochastic Oscillator
- ECOR 4.82
- SER 100.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.